Cogent Biosciences Company
Cogent Biosciences is a biopharmaceutical company that develops therapies for solid cancer tumors.
Investors
Technology:
Bioengineering
Industry:
Gene therapy, Public
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2014-01-01
Employees Number:
101-250
Funding Status:
IPO
Investors Number:
25
Total Funding:
432700000
Estimated Revenue:
$10M to $50M
Last Funding Date:
2022-06-13
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership